Conferences - Results from #20

Viewing 21-40 of 11532 articles

WCET 2024: Bladder Transplantation: Preclinical Work in Preparation for First-in-Human Case

WCET 2024: Panel: Robotic Platforms: Which Way Should We Go?

WCET 2024: The Impact of Laser Settings on Nephrolithiasis: Clinical Observations from the Post Market Thulium Fiber Laser Registry and Team of Worldwide Endourological Researchers (T.O.W.E.R) Consortium

WCET 2024: Robotic Simple Prostatectomy Followed by Radiation Therapy Versus Robotic Radical Prostatectomy: Propensity Matched Analysis of a Treatment Pathway for Men with Prostate Cancer and Prostatomegaly

WCET 2024: Panel: Artificial Intelligence (AI) in Endourology and Robotic Surgery

WCET 2024: Debate: Is Open Surgery Training Necessary in the Era of Robotics?

WCET 2024: State of the Art Lecture: The Role of Adjuvant and Salvage Radiation Therapy for Prostate Cancer

WCET 2024: Impact of Tumor Volume and Surgical Margins on Mortality Post-Robotic Radical Prostatectomy

WCET 2024: Development of Patient-Specific Nomogram for Clinical Decision-Making Between Single-Port versus Multi-Port Robotic Partial Nephrectomy: A Report from the Single Port Advanced Robotic Consortium

WCET 2024: Holmium Laser Versus Transurethral Resection of the Bladder Tumor for Non-Muscle Invasive Bladder Cancer: a 2-Year Follow-up Clinical Trial

WCET 2024: The Prostate Microbiome is Associated with Prostate Size in BPH Patients

WCET 2024: Evaluation of Thermal Injury During Treatment of Kidney and Ureteral Stones with the Thulium Fiber Laser: Insights from an In-Vivo Porcine Model

WCET 2024: Leveraging A Machine Learning Model To Predict Kidney Stone Composition: Implications For Treatment And Pathophysiology

BCANTT 2024: Rationally Engineered IL2 for Enhanced Treatment of Local and Metastatic Bladder Cancer

BCANTT 2024: Setting the Stage: BCG Unresponsive Disease

BCANTT 2024: Identifying Genetic Determinants and Vulnerabilities of Histologic Variants of Bladder Cancer

BCANTT 2024: Bladder Cancer Surveillance: Is Less More?

BCANTT 2024: Dissecting the Impact of E-Cadherin Loss on the Immune Microenvironment

BCANTT 2024: Exploring FGFR3 Inhibition as a Sensitizing Agent to Nectin-4 Antibody Drug Conjugate Therapy in Urothelial Carcinoma

BCANTT 2024: Using Implementation Science to Improve Surveillance for Early-Stage Bladder Cancer

1
2
3
4
5
6
7
8
9
10